- PoliticsBusiness Insider
- HealthAssociated Press
U.S. government officials are putting an early end to a study testing an Eli Lilly antibody drug for people hospitalized with COVID-19 because it doesn’t seem to be helping them. It is a setback for one of the most promising treatment approaches for COVID-19. President Donald Trump received a similar experimental, two-antibody drug from Regeneron Pharmaceuticals Inc. on an emergency basis when he was sickened with the coronavirus earlier this month.
China's top cyber authority said on Monday it would carry out a "rectification" of Chinese mobile internet browsers to address what it called social concerns over the "chaos" of information being published online. China's strict internet censorship rules have been tightened numerous times in recent years and in the latest crackdown, the Cyberspace Administration of China (CAC) has told firms operating mobile browsers that they have until Nov. 9 to conduct a "self examination" and rectify problems. "After the rectification, mobile browsers that still have outstanding problems will be dealt with strictly according to laws and regulations until related businesses are banned."
- PoliticsThe Conversation
- PoliticsUSA TODAY